Abiopharma

🔍 Otitoju Kolawole A. (Executive)

Company: 908 Devices Inc. (MASS)

Report Date: 2026-04-21

Detailed Transactions and Holdings:

• Acquired 146,789 shares of Stock Option (right to buy) at $7.26 per share (Derivative)
  Date: 2026-04-21 | Code: A | Expires: 2036-04-20 | equity_swap_involved: 0 | shares_owned_after: 146,789.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 110,193 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-21 | Code: A | equity_swap_involved: 0 | shares_owned_after: 110,193.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: One-third of the shares underlying the option become vested and exercisable on May 1, 2027, and the remaining two-thirds of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 24 months following May 1, 2027, subject to the reporting person's continued service through the applicable vesting date.
• F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
• F3: These RSUs vest in three substantially equal annual installments at the three anniversary dates following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.